Ebos Secures $217 Million in Capital Raise to Fund Pet Health Acquisition

Highlights:

• Ebos Group Limited (NZX: EBO) completes a $217 million institutional placement as part of a broader $270m equity raise.
• The funds will support its $115 million acquisition of SVS Veterinary Supplies.
• Retail investors to be offered up to $54 million in a non-underwritten share offer.

Major Institutional Placement Completed

Ebos Group Limited (NZX: EBO), a leading diversified healthcare and animal care company, has successfully completed a fully underwritten placement of new shares, raising approximately NZ$217 million. At the time of writing, this capital raise forms part of a larger $270 million equity raising initiative aimed at bolstering the company's expansion in the veterinary space.

The institutional placement attracted strong support from both new and existing shareholders, underscoring investor confidence in the company’s strategic direction. The offer was priced at a discount to market value, providing participants an incentive to back the firm’s latest acquisition.

SVS Veterinary Supplies Acquisition

Proceeds from the placement will be primarily used to fund Ebos’ acquisition of SVS Veterinary Supplies, a well-established pet medicine distributor, for NZ$115 million. The acquisition is expected to enhance Ebos’ footprint in the veterinary sector and expand its capabilities across Australasia.

The acquisition aligns with Ebos’ growth strategy to strengthen its animal health division, which has shown consistent revenue momentum in recent years.

Retail Offer to Follow

In addition to the institutional placement, Ebos has announced a non-underwritten retail entitlement offer to raise up to NZ$54 million. This allows eligible existing shareholders the opportunity to participate in the capital raising on similar terms.

The company said the equity raising will support long-term value creation and reinforce its position as a market leader in healthcare and animal care services.

Disclaimer for Kapitales Research

The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com